Surgalign Holdings General and Administrative Expenses 2011-2026 | SRGA

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses Surgalign Holdings

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
95.9 M	104 M	124 M	158 M	-	-	-	-	4.8 M	-	20 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
158 M	20 K	81.2 M

Quarterly General and Administrative Expenses Surgalign Holdings

2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
21.1 M	-	23.9 M	24.3 M	25.3 M	-	27.6 M	25.5 M	26.2 M	-	27.7 M	32.1 M	37.2 M	-	34.2 M	41.1 M	32.1 M	-	29.7 M	29.3 M	28.4 M	-	1.82 M	29.6 M	29.7 M	-	28.8 M	28.4 M	27.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
41.1 M	1.82 M	27.8 M

General and Administrative Expenses of other stocks in the Medical devices industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
AdaptHealth Corp. AHCO	382 M	$ 13.14	0.23 %	$ 1.78 B	USA
BIOLASE BIOL	10.2 M	-	-13.19 %	$ 166 K	USA
GenMark Diagnostics, Inc. GNMK	25.6 M	-	-	$ 1.77 B	USA
Allied Healthcare Products AHPI	7.11 M	-	3.58 %	$ 2.21 M	USA
Eargo EAR	54.3 M	-	-	$ 10.2 M	USA
Delcath Systems DCTH	43.5 M	$ 10.69	2.99 %	$ 383 M	USA
Apollo Endosurgery APEN	20.6 M	-	-	$ 475 M	USA
Obalon Therapeutics, Inc. OBLN	8.78 M	-	-5.86 %	$ 30.6 M	USA
Second Sight Medical Products EYES	1.11 M	-	-0.97 %	$ 54.4 M	USA
Electromed ELMD	39.3 M	$ 26.13	1.04 %	$ 221 M	USA
Avinger AVGR	14.1 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	40.2 M	-	-	$ 3.31 B	USA
EDAP TMS S.A. EDAP	5.9 M	$ 3.36	1.05 %	$ 126 M	France
Aziyo Biologics AZYO	15.1 M	-	1.37 %	$ 20.5 M	USA
BioSig Technologies BSGM	67.5 M	-	37.08 %	$ 85.7 M	USA
Conformis CFMS	28.8 M	-	-	$ 16.4 M	USA
ClearPoint Neuro CLPT	16.5 M	$ 11.21	0.22 %	$ 317 M	USA
Helius Medical Technologies HSDT	9.27 M	$ 2.09	2.21 %	$ 1.27 M	USA
Inspire Medical Systems INSP	625 M	$ 56.54	0.76 %	$ 1.66 B	USA
Cardiovascular Systems CSII	171 M	-	0.15 %	$ 844 M	USA
Cytosorbents Corporation CTSO	35.6 M	$ 0.63	2.87 %	$ 39.2 M	USA
CryoLife, Inc. CRY	141 M	-	-4.14 %	$ 702 M	USA
Invacare Corporation IVC	227 M	-	-	$ 24.7 M	USA
Soliton, Inc. SOLY	8.46 M	-	-1.42 %	$ 435 M	USA
LivaNova PLC LIVN	549 M	$ 60.35	0.42 %	$ 3.29 B	Britain
Hancock Jaffe Laboratories, Inc. HJLI	4.88 K	-	-1.98 %	$ 98.3 M	USA
IRIDEX Corporation IRIX	7.73 M	$ 1.08	4.37 %	$ 18.3 M	USA
Itamar Medical Ltd. ITMR	8.5 M	-	0.03 %	$ 1.58 B	Israel
Dynatronics Corporation DYNT	8.46 M	-	14.99 %	$ 929 K	USA
Misonix, Inc. MSON	18 M	-	-	$ 462 M	USA
Neovasc NVCN	14.7 M	-	-	$ 111 M	Canada
OrthoPediatrics Corp. KIDS	120 M	$ 15.26	1.29 %	$ 358 M	USA
Butterfly Network BFLY	39.8 M	$ 4.9	2.51 %	$ 1.04 B	USA
Intersect ENT, Inc. XENT	98.6 M	-	-	$ 955 M	USA
GBS GBS	8.88 M	-	-0.57 %	$ 7.12 M	USA
Globus Medical GMED	1.18 B	$ 90.84	0.7 %	$ 12.3 B	USA
NanoVibronix NAOV	7.63 M	-	-	$ 1.08 M	USA
CONMED Corporation CNMD	132 M	$ 37.36	1.77 %	$ 1.16 B	USA
Integer Holdings Corporation ITGR	212 M	$ 87.13	-1.61 %	$ 3.03 B	USA
Edwards Lifesciences Corporation EW	2.09 B	$ 83.61	0.1 %	$ 48.9 B	USA
Sintx Technologies SINT	6.2 M	$ 2.08	0.2 %	$ 5.77 M	USA
Stryker Corporation SYK	8.65 B	$ 304.09	-3.48 %	$ 116 B	USA
TransMedics Group TMDX	185 M	$ 100.78	-0.01 %	$ 3.43 B	USA
LENSAR LNSR	45.2 M	$ 5.21	-0.38 %	$ 62.3 M	USA
Tandem Diabetes Care TNDM	445 M	$ 19.81	1.46 %	$ 1.35 B	USA
Pulmonx Corporation LUNG	101 M	$ 1.33	3.91 %	$ 54.1 M	USA
MiMedx Group MDXG	56.5 M	$ 3.58	6.55 %	$ 529 M	USA
Myomo MYO	14 M	$ 0.87	1.21 %	$ 36.4 M	USA